Found 587 matching trials
A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers
PHASE2This is a phase II, observer-blind, multiple-centre, randomized, placebo-co...
Location
Changhua Christian Hospital
A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients
PHASE1Considerable progress in the treatment of metastatic melanoma has been made...
Location
Beijing Cancer Hospital
Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients
N/AThe purpose of this study is to collect data from patients by social media ...
Location
Lymphoma House086
Immunity and Safety of Covid-19 Synthetic Minigene Vaccine
PHASE1In December 2019, viral pneumonia caused by a novel beta-coronavirus (Covid...
Location
Shenzhen Geno-immune Medical Institute
TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer
PHASE2Status - CLOSED TO PATIENT ENROLLMENT (CNPE)
The study is being conducted ...
Location
Houston Methodist Hospital
ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer
PHASE1This is a single-arm, multicenter, phase II study designed to evaluate the ...
Location
Multiple Locations
Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors
PHASE1This is a Phase 1 open-label, multicenter study of the safety and tolerabil...
Location
City of Hope Medical Center
Cellular Immunotherapy Study for Brain Cancer
PHASE1The purpose of this research study to determine if treating recurrent malig...
Location
University of California, Los Angeles
GKL-006Allo Injection in Patients With Advanced Solid Tumors
PHASE1This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinet...
Location
Cancer Hospital Chinese Academy of Medical Sciences
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
PHASE1This phase I trial studies the side effects and best dose of ipilimumab and...